Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xihuang Pill with Neoadjuvant Chemotherapy for Breast Cancer
NCT05914753Unknown
- Sponsor
- Zhejiang Provincial People's Hospital
- Start
- Jul 2023
- Primary completion
- Jun 2024
- Modality
- HM (Herbal Medicine), Combination Drug
01
Overview
Randomised, open-label trial of Xihuang Capsule in breast cancer (2 arms), sponsored by Zhejiang Provincial People's Hospital. Primary endpoint: Pathological Complete Response at 6 months. Status: unknown.
02
Drugs
Xihuang Capsule
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT05914753.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05914753.